EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Inflammation in Diabetic Kidney Disease Is Linked to Gut Dysbiosis and Metabolite Imbalance

Xueting Zheng, Xiaoyan Luo, Yi Zhang, Zhiyan Zou, Jiayi Yang, Huan Liu, Zhou Lu, Fangfang Cao, Xilian Wang, Xinyun Ge, Xiaoan Li, Jiali Wang

Journal of Diabetes · 2025-12 · 17 (12)

DOI: 10.1111/1753-0407.70175 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Background Diabetic kidney disease (DKD) is characterized by a sustained pro‐inflammatory response of the immune system, which leads to renal failure progression and related complications. Emerging evidence suggests that gut microbiota dysregulation may be a pathogenic mediator in DKD, while mechanisms remain unclear. This study aimed to identify differences in the gut microbiota of the DKD group and healthy controls (HC). Methods Gut microbiota composition was determined using shotgun metagenomic sequencing on fecal samples; serum cytokines were measured via ELISA, immune phenotypes were detected using flow cytometry. Results Significant differences in gut microbiota diversity and richness were observed between patients with DKD and HC, with higher abundances of Enterobacteriaceae, Serratia , and Shigella in the DKD group than in the HC group. Additionally, CD3+ (especially CD4+) T cells were significantly higher in the renal tissue of the DKD group than the HC group. Flow cytometry identified significantly higher circulating levels of NKT cells and CD8+ T cells and lymphocyte ratio in HC than in DKD. CD4+ cells, CD4+ TCM cells, CD8+ TCM cells, and the CD4+/CD8+ cell ratio were significantly higher in the DKD group than in the HC group, as were levels of pro‐inflammatory mediators, including IL‐6, TNF‐α, and sCD14, and expression of the gut barrier dysfunction marker ZO‐1. Conclusions Gut barrier dysfunction and gut microbiota imbalance may mediate the pro‐inflammatory immune phenotype observed in patients with DKD and thereby contribute to DKD progression. These findings underscore the important role of the microbiota–immune axis in the development of DKD.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →